When treating a bulky squamous cell carcinoma of the anal canal, do you try to limit the dose to the external anal sphincter to any particular number to reduce the risk of chronic fecal incontinence?

Especially if using an escalated dose such as 58 Gy in 29 fractions for a T3-T4 primary